Memphasys Ltd

IG7

Company Profile

  • Business description

    Memphasys Ltd is an Australian reproductive biotechnology company developing and commercializing novel reproduction and fertility solutions for humans and animals. The products in its development pipeline include a range of devices, media, and in vitro diagnostic solutions. The company is currently focused on the commercialisation of its patented Felix System, a novel bio-separation technology for assisted reproduction, designed to revolutionise sperm separation in assisted reproductive technology (ART) by providing a rapid, gentle, and automated process. The group has only one operating segment, being Reproductive Technologies, the assets and liabilities of which are located in Australia.

  • Contact

    34-36 Richmond Road
    Level 1
    Homebush West
    SydneyNSW2140
    AUS

    T: +61 284157300

    https://www.memphasys.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2026

    Employees

    28

Stocks News & Analysis

stocks

Market too pessimistic about unloved ASX health care share

Our analysts believe a long-term margin recovery is underway.
stocks

Two overvalued ASX shares to avoid

Both shares trade at a significant premium to our fair value.
stocks

Materially undervalued ASX tech share

Long reinvestment runway supports our thesis on ASX technology company.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,888.7017.10-0.19%
CAC 408,025.8066.130.83%
DAX 4023,464.63225.450.97%
Dow JONES (US)47,112.45664.181.43%
FTSE 1009,609.5374.620.78%
HKSE26,013.33118.780.46%
NASDAQ23,025.59153.590.67%
Nikkei 22549,509.14849.621.75%
NZX 50 Index13,562.0181.580.61%
S&P 5006,765.8860.760.91%
S&P/ASX 2008,596.3019.70-0.23%
SSE Composite Index3,875.485.450.14%

Market Movers